OR WAIT null SECS
has unveiled an expansion into the US marketplace, with the launch of its New York office and the appointment of Susan Pavone, Associate Director of US Business Operations.
The expansion of US based operations through the launch of American headquarters, together with Susan Pavone’s appointment, will enable ClinTec to offer prospective US clients the chance to access global clinical research capabilities through a single partner.
President & CEO of ClinTec International, Dr Rabinder Buttar, commented: “We have established a strong presence in the international marketplace by placing clinical research staff in all key emerging, and established markets. The pharmaceutical industry is currently searching for new ways of working and delivering global solutions. ClinTec’s ability to harness global strength, coupled with local expertise, will be of great value to US pharmaceutical companies. Our new Associate Director of (US) Operations, Susan Pavone, has extensive knowledge of international clinical research and the new US facilities will prove an invaluable asset to American companies looking to tap into our globalised resources.”